A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age

Condition:   Avian InfluenzaInterventions:   Biological: aH5N1c;   Biological: PlaceboSponsors:   Seqirus;   Biomedical Advanced Research and Development AuthorityRecruiting - verified July 2016

Source: ClinicalTrials.gov - July 18, 2016 Category: Research Source Type: clinical trials